Correlation Engine 2.0
Clear Search sequence regions


  • ARID5B (1)
  • blood cells (1)
  • Bmi1 protein (1)
  • child (1)
  • chimera (1)
  • engraft (1)
  • EZH2 (1)
  • factor (3)
  • fetal blood (1)
  • gene (1)
  • graft (1)
  • hematopoiesis (8)
  • humans (1)
  • impairs (3)
  • isoforms (7)
  • KLF2 (1)
  • marrow (2)
  • mice (3)
  • myeloid leukemia (5)
  • Polycomb (2)
  • regulates (1)
  • Sall4 (12)
  • SALL4a (4)
  • SALL4b (5)
  • stem cells (7)
  • target genes (1)
  • Sizes of these terms reflect their relevance to your search.

    Sal-like protein 4 (SALL4) is a transcription factor that exists in two splice isoforms, SALL4a and SALL4b, and regulates transcription in embryonic stem cells, hematopoiesis, and acute myeloid leukemia. Constitutive overexpression of SALL4 in mice induces acute myeloid leukemia. Interestingly, a potential benefit of using SALL4 to facilitate ex vivo hematopoietic stem cell expansion has been proposed. However, distinct roles for how SALL4 contributes to normal versus malignant processes remain undefined. Here we show that SALL4b is the predominant isoform in murine hematopoietic stem cells and progenitors. Overexpression of either SALL4 isoform in hematopoietic stem cells or progenitors impairs hematopoietic colony formation and expansion in vitro. Lineage-negative bone marrow overexpressing SALL4b fails to engraft and reconstitute hematopoiesis when transplanted. We found that both SALL4a and SALL4b overexpression impair hematopoiesis, in part through dose-dependent repression of BMI1. Additionally, we have identified the following potential novel SALL4 target genes in hematopoiesis: ARID5B (SALL4a and SALL4b), EZH2, and KLF2 (SALL4a). Lastly, we found that SALL4 expression is variable in acute myeloid leukemia, ranging from no expression to levels comparable to embryonic stem cells. These results show that SALL4 isoforms contribute to only a subset of acute myeloid leukemia and that overexpression of SALL4 isoforms impairs hematopoiesis through repression of BMI1. Together these data demonstrate the sensitivity of hematopoiesis to appropriately balanced SALL4 expression, highlighting the importance of regulating this dynamic in potential therapeutic applications such as ex vivo stem cell expansion. Copyright © 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

    Citation

    Samuel Milanovich, Jonathan Peterson, Jeremy Allred, Cary Stelloh, Kamalakannan Rajasekaran, Joseph Fisher, Stephen A Duncan, Subramaniam Malarkannan, Sridhar Rao. Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner. Experimental hematology. 2015 Jan;43(1):53-64.e1-8

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 25246269

    View Full Text